Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Remarks:
Type of genotoxicity: gene mutation
Type of information:
experimental study
Adequacy of study:
other information
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Comparable to guideline study with acceptable restrictions

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1986
Report date:
1986

Materials and methods

Principles of method if other than guideline:
The point-mutagenic effects were investigated in doses up to 12000 µg/plate on four histidine-auxotropic Salmonella typhimurium LT2 strains, for each substance, dose level and strain 4 plates were used. After an incubation period of 48 h the number of revertant colonies per plate were counted.
GLP compliance:
no
Type of assay:
bacterial reverse mutation assay

Test material

Constituent 1
Chemical structure
Reference substance name:
Methyl 3-aminocrotonate
EC Number:
238-056-5
EC Name:
Methyl 3-aminocrotonate
Cas Number:
14205-39-1
Molecular formula:
C5 H9 O2 N
IUPAC Name:
methyl 3-aminocrotonate
Details on test material:
3-Aminocrotonsäuremethylester, white powder, content and identity not certified

Method

Target gene:
histidin gene locus
Species / strain
Species / strain / cell type:
S. typhimurium, other: TA 1535, TA 100, TA 1537, TA 98
Metabolic activation:
with and without
Metabolic activation system:
rat liver homogenate (S-9 mix)
Test concentrations with justification for top dose:
3-Aminocrotonsäuremethylester: 375-12000 µg/plate
Sodium azide: 10 µg/plate
Nitrofurantoin: 0.2 µg/plate
4-Nitro-o-phenylendiamin: 10 µg/plate (TA 1537) and 0.5 µg/plate (TA 98)
2-Aminoanthracene: 3 µg/plate
Controls
Untreated negative controls:
yes
Negative solvent / vehicle controls:
yes
Remarks:
Ethanol
True negative controls:
no
Positive controls:
yes
Positive control substance:
other: Sodium azide (TA 1535, without S9-mix), Nitrofurantoin (TA 100, without S9-mix), 4-Nitro-o-phenylendiamin (TA 1537 and 98, without S9-mix), 2-Aminoanthracene (with S9-mix)

Results and discussion

Test results
Species / strain:
S. typhimurium, other: TA 1535, TA 100, TA 1537, TA 98
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Remarks:
at doses of 1500 µg/plate and higher bacteriotoxic effects, but these were only weak strainspecific effects, so that this range could nevertheless be used for evaluation purposes
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Remarks on result:
other: all strains/cell types tested
Remarks:
Migrated from field 'Test system'.

Applicant's summary and conclusion

Executive summary:

Methyl 3 -aminocrotonate was tested in the Salmonella/microsome test for point-mutagenic effects in doses up to 12000 µg/plate on the four histidine-auxotrophic Salmonella typhimurium LT2 strains TA 1535, TA 100, TA 1537 and TA 98.

Doses up to and including 750 µg/plate did not cause any bacteriotoxic effects and at higher doses the substance had only a weak strainspecific bacteriotoxic effect, so that this range could nevertheless be used for evaluation purposes.

No evidence for a mutagenic activity of methyl 3 -aminocrotonate was found.